Title : Inhibition of PPARγ, adipogenesis and insulin sensitivity by MAGED1.

Pub. Date : 2018 Nov 1

PMID : 30121577






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. 2,4-thiazolidinedione peroxisome proliferator activated receptor gamma Mus musculus
2 Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. 2,4-thiazolidinedione peroxisome proliferator activated receptor gamma Mus musculus
3 Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. 2,4-thiazolidinedione peroxisome proliferator activated receptor gamma Mus musculus
4 Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. 2,4-thiazolidinedione peroxisome proliferator activated receptor gamma Mus musculus
5 Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. 2,4-thiazolidinedione peroxisome proliferator activated receptor gamma Mus musculus